Automation is not a four-letter word and it’s not something to curse. Especially, for professionals in highly-regulated industries, such as life sciences. Sustaining a competitive advantage goes beyond simply modernizing technologies and lean processes. It’s about empowering people to leverage automation and real-time insights to work smarter and adapt faster to changing regulatory conditions. And, it’s about ensuring that innovative, high-quality products make it to market faster and more affordably.

As digital technology continues to drive the next wave of transformation across all industries and aspects of work – from pharmaceuticals to heavy machinery – it’s important to explore the fear versus the reality that these technologies provide. Just as quality and productivity should always be in sync, so too can automation and improved human capacity.

Leveraging today’s revolutionary technology initiatives like Industry 4.0, digital thread, robotic process automation and countless more means staying ahead of the competition, but it requires the right manufacturing software – and going fully paperless. This white paper is your guide to the past, present and future of manufacturing software solutions.

Today, the next wave of life sciences firms is embarking on Industrial Transformation (IX) of manufacturing and quality. These companies are not the early innovators, but rather the next and much larger wave striving to leverage lessons and more mature tech vetted by the early innovators to quickly implement higher success, lower risk initiatives.

This research provides new perspectives to guide these organizations.

The world of medical device manufacturing will be a thrilling and challenging space in 2020 as record-breaking revenues, ever-changing regulatory conditions, technology innovations and promising new market opportunities collide. The industry grew at a record 7% clip in 20191 — a nine-year high — and total global revenues are expected to reach $483.4 billion in 2020.

This article will look at some of the trends anticipated to make a substantial impact on the medtech sector in 2020 and offers suggestions about how manufacturers can best position themselves to roll with and benefit from those changes.